Skip to content

The Swedish Birth Seat Trial

The Swedish Birth Seat Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01182038
Enrollment
1002
Registered
2010-08-16
Start date
2007-11-30
Completion date
2009-07-31
Last updated
2010-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Outcomes, Instrumental Vaginal Births, Maternal Blood Loss, Oxytocin Augmentation for Labor, Perineal Outcomes

Keywords

birth seat, childbirth, instrumental delivery, upright position

Brief summary

The purpose of this study is to determine whether birth on a birthing seat will effect numbers of instrumentally assisted vaginal births, vaginal traumas, blood loss,use of artificial oxytocin for labour augmentation and fetal outcomes.

Interventions

DEVICEBirthRite birthing seat

Randomization takes place on admission to the labor ward when the participants are in active labor.Participants in this arm were to sit on the seat for 20 minute periods.After these 20 minutes, the participant should stand and mobilize during two to three contractions, before resuming the birth seat position. If progress of the descent of the fetal head was obvious the participant was not asked to mobilize.

Sponsors

The Stig & Ragna Gorthon Foundation, Helsingborg
CollaboratorUNKNOWN
Helsingborgs Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* nulliparous women who understood the Swedish language sufficiently well to receive information and give informed consent * a normal pregnancy,singleton fetus in cephalic presentation * spontaneous onset of labor occurring between gestational weeks 37 + 0 and 41 + 6 * Body Mass Index less (BMI) than thirty * gestational diabetes not requiring medical treatment * women who were planning a vaginal birth after a caesarean section (VBAC) * women induced because of spontaneous rupture of membranes with no spontaneous contractions for longer than twenty-four hours

Exclusion criteria

* multiparous women * birth before gestational week 37 * breech presentation * maternal BMI more than 30 * multiple pregnancy * infectious disease * pre-eclampsia or other conditions requiring medical care

Design outcomes

Primary

MeasureTime frameDescription
Instrumental vaginal birthsRecorded within 6 hours postpartumInstrumental births include vacuum extraction and forceps delivery.

Secondary

MeasureTime frameDescription
Postpartum blood lossUp to 24 hours after birthBlood loss postpartum is weighed and measured and maternal hemoglobin levels are registered.
Administration of oxytocin for augmentation of laborDuring labor and birth up to 36 hours postpartum
Perineal outcomesUp to 36 hours after birthPerineal outcomes include vaginal and perineal traumas, episiotomies and perineal edema.
Fetal outcomesUp to 36 hours after birthFetal outcomes include Apgar scores, cord blood pH levels and admissions to the NICU.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026